ArticleCancers2022

Two Doses of BNT162b2 mRNA Vaccine in Patients after Hematopoietic Stem Cell Transplantation: Humoral Response and Serological Conversion Predictors.

Maciej Majcherek et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.